NYSE · ZBH · Medical Devices
Zimmer Biomet Holdings, Inc. (ZBH) stock analysis
- ZBH gained 1.2% over the past month versus 0.0% for the S&P 500, ranking 289th of 497 S&P 500 stocks.
- Over 12 months it returned −7.2%, 23.0 points behind the S&P 500, and trades 8.3% below its 52-week high.
- In the last 30 days 0 analysts raised earnings estimates and 1 cut; forward EPS moved −0.2% (+0.6% over 90 days).
- It sits in the Surgical & interventional devices segment of the Medtech, Diagnostics & Care, where the 1-month median return is +2.3%.
- The daily chart reads Trend transition · Unresolved structure (since Oct 15, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 15, 2026
- Price and averages have mixed alignment
- EMA50 is approximately flat
- Neither a stable trend nor a range is confirmed
96 occurrences in 10 years. The median move over the next 20 sessions was +0.2%, positive 51% of the time, against +0.4% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
22 analysts cover the stock
Where it sits in the supply chain
Medtech, Diagnostics & Care · Devices, supplies & tests
Treatment devices and implants depend on installations and procedure volume.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Themes
- MedTech3M rank 35 / 90
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.